Abiopharma

🔍 Johnston Brett Wade (Executive)

Company: Quest Resource Holding Corp (QRHC)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 3,246 shares of Common Stock at $1.46 per share (Direct)
  Date: 2026-08-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 88,481.00 | transaction_form_type: 4
• Acquired 100,000 shares of Common Stock at $1.46 per share (Direct)
  Date: 2026-08-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 188,481.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: These reported securities represent restricted stock units ("RSUs") granted on August 13, 2026 under the Issuer's 2024 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting. The RSUs are scheduled to vest as follows: one-third upon the first anniversary of the Grant Date, one-third upon the second anniversary of the Grant Date, and one-third upon the third anniversary of the Grant Date.
• F2: Includes (a) 6,667 RSUs that are scheduled to vest on June 26, 2027, (b) 26,667 RSUs that are scheduled to vest in two equal installments on August 13, 2027 and August 13, 2028, (c) 100,000 RSUs that are scheduled to vest in three equal installments on August 13, 2027, August 13, 2028 and August 13, 2029, (d) 5,767 deferred stock units ("DSUs") (such shares of common stock underlying such DSUs shall be issued upon the Reporting Person's separation from service with the Issuer) and (e) 49,380 shares of common stock beneficially owned by the Reporting Person.